Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
about
Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genomeIdentification of an Epstein-Barr virus-coded thymidine kinase.Maple syrup urine disease in Mennonites. Evidence that the Y393N mutation in E1 alpha impedes assembly of the E1 component of branched-chain alpha-keto acid dehydrogenase complexEpstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replicationMolecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complexHuman endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomasT cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residuesSpecificity prediction of adenylation domains in nonribosomal peptide synthetases (NRPS) using transductive support vector machines (TSVMs)Epstein-Barr virus U leader exon contains an internal ribosome entry siteEpstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosisType 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese familyThe Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways.Proteasome subunits mRNA expressions correlate with male BMI: implications for a role in obesity.Voltage-dependent anion channel (VDAC) is involved in apoptosis of cell lines carrying the mitochondrial DNA mutation.Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects.Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritisHuman monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytesEpstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptorMitochondrial biogenesis dysfunction and metabolic dysfunction from a novel mitochondrial tRNAMet 4467 C>A mutation in a Han Chinese family with maternally inherited hypertensionTyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latencyCD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discovery.The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersMutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndromeAutostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakiaAntiviral cell-mediated immune responses and effect of chromosome polymorphism in Herpesvirus saimiri-infected monkeys.Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human seraRelationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virusOrganization of repeated regions within the Epstein-Barr virus DNA moleculeEpstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.Human cell lines containing Epstein-Barr virus but distinct from the common B cell lymphoblastoid lines.Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families.Mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree.
P2860
Q21090514-B03D32A7-F4F0-4911-BC96-3007F5CBBE09Q24531739-5023FC78-76C0-45DA-9C2A-05B2DDC2E473Q24631872-A1AD7C05-9FCF-4A72-B4B4-3370F17F93DAQ24671870-84EA7303-9B6A-4238-B1F6-C15379EB16F6Q24672679-7AA4E1ED-7990-4491-915D-CA8853B370FEQ24677052-8F876BBF-D5D7-4341-B089-0BDFB3EC428BQ24679910-E4A5597D-5F27-4B4E-A03D-8087F4936E83Q24811842-F5E17805-758F-4BE8-A428-787E63CAB4E7Q28205747-910F2339-60C4-4389-9228-B14C70D49907Q28731829-B04DA626-805C-45F8-973E-550AC0C3612DQ30305830-5D9949E4-2BD4-4F5A-ABEF-D2CE4A7BB947Q30452144-AF9BBBCB-1974-4FA3-913E-2812DBCC197CQ30452157-B24FB76B-F07A-41C1-A576-DFC30AF65324Q30499211-1D5F434D-ACA1-4901-BD94-5E8E6547B1FAQ31561068-08007899-BCDE-4CA7-93C9-429685F2FB0AQ33402431-8CF216C6-7CB9-4CCF-B099-356DDBA02ADAQ33515437-B86D03A5-85F1-4161-B710-1F09C2B83A99Q33555983-2C3775D7-454B-4506-9FF6-44289B5236CDQ33556764-77783287-4908-4D2A-BF42-30DDD2D7C174Q33557110-5A5820D5-BD7F-4B94-81A1-EB31A4DE8D9DQ33576126-A8F3F560-C909-4A3F-8DFB-774A2069A597Q33682618-024FE963-AD7F-4E86-B7CD-DCE11095B3D1Q33780440-33FEF4C0-4098-43EE-B24B-142A5A1205F1Q33784647-FCFE9B69-264D-4197-8819-F692A4638CB0Q33804193-E77B3F30-2EB6-48F1-8FA0-196A680A7A01Q33810163-62081C90-ABC1-4C44-8FDD-0292AF02305EQ33845947-30C76E53-C46C-4EA3-B0D1-C1D86A11ABF1Q33850305-1A09C6AF-6218-46EB-B388-48E569DC8379Q33851925-4CC00DAF-947D-4C4B-8307-31C61F27F760Q33891606-6F2C3B3A-FB78-4DFA-A9AA-2ADF7CDB4D09Q33899614-3883EEED-109B-4699-A27B-D1D16F06DF73Q33905718-B0D9FF8B-B4B0-4826-8086-74F6637B084FQ33907657-49993F68-2752-4209-9E80-9B862FF6E173Q33908216-614C1697-75BC-4459-9A14-ED739A446DDAQ33913142-7CCFA5DE-F6EC-43C4-8FC7-B6DB00E916A1Q33918770-2862AAEE-F562-404D-AE19-62706E580F6BQ33937673-CEA4466F-4083-4A02-97C2-960C9CC0A004Q33990622-2BA045CC-FE2A-43B4-8138-4D38A30B6359Q34000668-218DABE2-2EA1-4BB4-B09A-E948212E4210Q34007628-0D78ED69-744F-4702-8618-718BD0002B08
P2860
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
description
1973 nî lūn-bûn
@nan
1973 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
@ast
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
@en
type
label
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
@ast
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
@en
prefLabel
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
@ast
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
@en
P2860
P356
P1476
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
@en
P2093
P2860
P304
P356
10.1073/PNAS.70.1.190
P407
P577
1973-01-01T00:00:00Z